logo
Plus   Neg
Share
Email

NextEra Energy To Sell $2.5 Bln Of Equity Units

NextEra Energy Inc. (NEE) said that it has agreed to sell $2.5 billion of equity units to J.P. Morgan, Wells Fargo Securities, and BofA Securities. It expects to close the deal on February 21, 2020.

The company noted that each equity unit will be issued in a stated amount of $50. Each equity unit will consist of a contract to purchase NextEra Energy common stock in the future and a 5% undivided beneficial ownership interest in a NextEra Energy Capital Holdings debenture due March 1, 2025, to be issued in the principal amount of $1,000.

The debentures will be guaranteed by NextEra Energy Capital Holdings' parent company, NextEra Energy Inc. Total annual distributions on the equity units will be at the rate of 5.279%, consisting of interest on the debentures and payments under the stock purchase contracts.

The company noted that each stock purchase contract will require the holder to purchase NextEra Energy common stock for cash, based on a per-share price range of $282.04 to $352.55. The higher end of this price range reflects a premium of 25% over the New York Stock Exchange closing price of NextEra Energy common stock on February 18, 2020, which was $282.04. The holders must complete the stock purchase by no later than March 1, 2023, and their purchase obligations may be satisfied with proceeds raised from remarketing the debentures that comprise part of their equity units.

The net proceeds from the sale of the equity units, which are expected to be about $2.42 billion, will be added to the general funds of NextEra Energy Capital Holdings.

NextEra Energy Capital Holdings expects to use its general funds to fund investments in energy and power projects and for other general corporate purposes, including the repayment of all or a portion of NextEra Energy Capital Holdings' outstanding commercial paper obligations.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) expects that its first-quarter operating profit will increase about 2.73 percent from last year, sales will also increase 4.98 percent. JPMorgan Chase CEO Jamie Dimon said it expects the bank's earnings to be "down meaningfully" in 2020 due to the disruptions created by coronavirus pandemic. He also noted that the U.S. was not adequately prepared for the pandemic. In his annual letter to the company's shareholders, Dimon said that the bank's board may consider suspending the dividend in an extremely adverse scenario. The U.S. Food and Drug Administration launched a national effort to facilitate the development of blood-related therapies to combat the ongoing coronavirus (COVID-19) pandemic. The FDA is focused on two investigational therapies derived from human blood called convalescent plasma and hyperimmune globulin, which are antibody-rich blood products made from blood donated by people who have recovered.
Follow RTT
>